Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO25). We employs the Adenovirus (SV40-Cy5-PAX-EcoRI) vector components and the SynExpress system of the miRNA Prime Editing/Delayed feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO25
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy5
Promoter
SV40
Effector Gene
PAX
Insertion Sites
EcoRI
Gene Modification
Prime Editing
Modification Domain
miRNA
Carrier Type
Adenovirus
Transformation Accuracy
0.9
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.